The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 08, 2015

Filed:

Mar. 27, 2009
Applicants:

William F Mckay, Memphis, TN (US);

Christopher M Hobot, Tonka Bay, MN (US);

Danielle Biggs, Collierville, TN (US);

Katara Shaw, Birmingham, AL (US);

John Myers Zanella, Cordova, TN (US);

Vanja M King, Memphis, TN (US);

Stephen Mark Cox, Inver Grove Heights, MN (US);

Kathy L Remsen, Germantown, TN (US);

Inventors:

William F McKay, Memphis, TN (US);

Christopher M Hobot, Tonka Bay, MN (US);

Danielle Biggs, Collierville, TN (US);

Katara Shaw, Birmingham, AL (US);

John Myers Zanella, Cordova, TN (US);

Vanja M King, Memphis, TN (US);

Stephen Mark Cox, Inver Grove Heights, MN (US);

Kathy L Remsen, Germantown, TN (US);

Assignees:

Warsaw Orthopedic, Inc., Warsaw, IN (US);

Medtronic, Inc., Minneapolis, MN (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61F 13/00 (2006.01); A61K 31/58 (2006.01); A61K 31/585 (2006.01); A61K 9/00 (2006.01); A61K 9/16 (2006.01);
U.S. Cl.
CPC ...
A61K 31/585 (2013.01); A61K 9/0024 (2013.01); A61K 9/1647 (2013.01);
Abstract

Effective treatments of pain and inflammation are provided. Through the administration of an effective amount of fluocinolone at or near a target site, one can reduce, prevent or treat inflammation and pain and autoimmune disorders. In various embodiments, fluocinolone formulations may be provided within biodegradable polymers to reduce, prevent or treat sciatic pain and/or inflammation. In various embodiments, prevent transplant rejection for at least twenty-five days. In some embodiments, the pain relief can be for at least fifty days, at least one hundred days, at least one hundred and thirty-five days or at least one hundred and eighty days.


Find Patent Forward Citations

Loading…